Source link : https://www.newshealth.biz/health-news/novel-triple-hormone-agonist-boosts-beta-cell-function-in-t2d/
ORLANDO — An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks of treatment with retatrutide, people with type 2 diabetes on most doses had significantly larger improvements in fasting glucose than placebo or […]
Author : News Health
Publish date : 2024-06-23 21:21:21
Copyright for syndicated content belongs to the linked Source.
Categories